Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nicotinic acid receptor activity	HCAR3 HCAR2	2.33e-06	2	31	2	GO:0070553
GeneOntologyMolecularFunction	nucleotide receptor activity	HCAR3 HCAR2	5.28e-04	22	31	2	GO:0016502
GeneOntologyMolecularFunction	purinergic nucleotide receptor activity	HCAR3 HCAR2	5.28e-04	22	31	2	GO:0001614
GeneOntologyBiologicalProcess	positive regulation of adiponectin secretion	HCAR3 HCAR2	1.31e-05	4	31	2	GO:0070165
GeneOntologyBiologicalProcess	adiponectin secretion	HCAR3 HCAR2	6.09e-05	8	31	2	GO:0070162
GeneOntologyBiologicalProcess	regulation of adiponectin secretion	HCAR3 HCAR2	6.09e-05	8	31	2	GO:0070163
Domain	HCAR2/3_rcpt	HCAR3 HCAR2	2.67e-06	2	31	2	IPR028017
Domain	FA	EPB41L4A FARP1	2.06e-04	13	31	2	SM01195
Domain	FERM-adjacent	EPB41L4A FARP1	2.06e-04	13	31	2	IPR014847
Domain	FA	EPB41L4A FARP1	2.06e-04	13	31	2	PF08736
Domain	Ez/rad/moesin-like	EPB41L4A FARP1	5.49e-04	21	31	2	IPR000798
Domain	FERM_CS	EPB41L4A FARP1	7.19e-04	24	31	2	IPR019747
Domain	FERM_C	EPB41L4A FARP1	8.45e-04	26	31	2	PF09380
Domain	FERM_C	EPB41L4A FARP1	9.12e-04	27	31	2	SM01196
Domain	FERM_PH-like_C	EPB41L4A FARP1	9.12e-04	27	31	2	IPR018980
Domain	FERM_N	EPB41L4A FARP1	1.36e-03	33	31	2	IPR018979
Domain	FERM_N	EPB41L4A FARP1	1.36e-03	33	31	2	PF09379
Domain	FERM_M	EPB41L4A FARP1	2.64e-03	46	31	2	PF00373
Domain	FERM_central	EPB41L4A FARP1	2.99e-03	49	31	2	IPR019748
Domain	FERM_domain	EPB41L4A FARP1	2.99e-03	49	31	2	IPR000299
Domain	-	EPB41L4A FARP1	2.99e-03	49	31	2	1.20.80.10
Domain	FERM_1	EPB41L4A FARP1	3.11e-03	50	31	2	PS00660
Domain	FERM_2	EPB41L4A FARP1	3.11e-03	50	31	2	PS00661
Domain	Band_41_domain	EPB41L4A FARP1	3.11e-03	50	31	2	IPR019749
Domain	B41	EPB41L4A FARP1	3.11e-03	50	31	2	SM00295
Domain	FERM/acyl-CoA-bd_prot_3-hlx	EPB41L4A FARP1	3.11e-03	50	31	2	IPR014352
Domain	FERM_3	EPB41L4A FARP1	3.11e-03	50	31	2	PS50057
Pubmed	Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms.	HCAR3 HCAR2	8.20e-07	2	32	2	31366236
Pubmed	GPR109A gene deletion ameliorates gonadectomy-induced bone loss in mice.	HCAR3 HCAR2	8.20e-07	2	32	2	35489706
Pubmed	PUMA-G, an IFN-gamma-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily.	HCAR3 HCAR2	8.20e-07	2	32	2	11745392
Pubmed	Molecular identification of high and low affinity receptors for nicotinic acid.	HCAR3 HCAR2	8.20e-07	2	32	2	12522134
Pubmed	The role of HCA2 (GPR109A) in regulating macrophage function.	HCAR3 HCAR2	8.20e-07	2	32	2	23882124
Pubmed	Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis.	HCAR3 HCAR2	8.20e-07	2	32	2	30659164
Pubmed	Niacin Ameliorates Hepatic Steatosis by Inhibiting De Novo Lipogenesis Via a GPR109A-Mediated PKC-ERK1/2-AMPK Signaling Pathway in C57BL/6 Mice Fed a High-Fat Diet.	HCAR3 HCAR2	8.20e-07	2	32	2	31858105
Pubmed	Deficiency of metabolite sensing receptor HCA2 impairs the salutary effect of niacin in hemorrhagic shock.	HCAR3 HCAR2	8.20e-07	2	32	2	30625381
Pubmed	Crosstalk between microbiome, regulatory T cells and HCA2 orchestrates the inflammatory response in a murine psoriasis model.	HCAR3 HCAR2	8.20e-07	2	32	2	36891315
Pubmed	Exploring the role of the metabolite-sensing receptor GPR109a in diabetic nephropathy.	HCAR3 HCAR2	8.20e-07	2	32	2	32068460
Pubmed	Involvement of the Niacin Receptor GPR109a in the LocalControl of Glucose Uptake in Small Intestine of Type 2Diabetic Mice.	HCAR3 HCAR2	8.20e-07	2	32	2	26371038
Pubmed	Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets.	HCAR3 HCAR2	8.20e-07	2	32	2	25622782
Pubmed	The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome.	HCAR3 HCAR2	8.20e-07	2	32	2	30657794
Pubmed	Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease.	HCAR3 HCAR2	8.20e-07	2	32	2	34653248
Pubmed	Activated niacin receptor HCA2 inhibits chemoattractant-mediated macrophage migration via Gβγ/PKC/ERK1/2 pathway and heterologous receptor desensitization.	HCAR3 HCAR2	8.20e-07	2	32	2	28186140
Pubmed	Nicotinic acid inhibits glucose-stimulated insulin secretion via the G protein-coupled receptor PUMA-G in murine islet β cells.	HCAR3 HCAR2	8.20e-07	2	32	2	21441844
Pubmed	Ketones and pain: unexplored role of hydroxyl carboxylic acid receptor type 2 in the pathophysiology of neuropathic pain.	HCAR3 HCAR2	8.20e-07	2	32	2	30085883
Pubmed	Phenolic acids suppress adipocyte lipolysis via activation of the nicotinic acid receptor GPR109A (HM74a/PUMA-G).	HCAR3 HCAR2	8.20e-07	2	32	2	19136666
Pubmed	GPR109a Regulates Phenotypic and Functional Alterations in Macrophages and the Progression of Type 1 Diabetes.	HCAR3 HCAR2	8.20e-07	2	32	2	36208084
Pubmed	Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytes.	HCAR3 HCAR2	8.20e-07	2	32	2	20655299
Pubmed	G Protein-Coupled Receptor 109A and Host Microbiota Modulate Intestinal Epithelial Integrity During Sepsis.	HCAR3 HCAR2	8.20e-07	2	32	2	30271409
Pubmed	Nicotinic acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation.	HCAR3 HCAR2	8.20e-07	2	32	2	21655214
Pubmed	Evidence for constitutive dimerization of niacin receptor subtypes.	HCAR3 HCAR2	8.20e-07	2	32	2	20380810
Pubmed	Melatonin alleviates titanium nanoparticles induced osteolysis via activation of butyrate/GPR109A signaling pathway.	HCAR3 HCAR2	8.20e-07	2	32	2	34092246
Pubmed	GPR109A mediates the effects of hippuric acid on regulating osteoclastogenesis and bone resorption in mice.	HCAR3 HCAR2	8.20e-07	2	32	2	33420329
Pubmed	G Protein-Coupled Receptor 109A Maintains the Intestinal Integrity and Protects Against ETEC Mucosal Infection by Promoting IgA Secretion.	HCAR3 HCAR2	8.20e-07	2	32	2	33488584
Pubmed	The Immunometabolomic Interface Receptor Hydroxycarboxylic Acid Receptor 2 Mediates the Therapeutic Effects of Dimethyl Fumarate in Autoantibody-Induced Skin Inflammation.	HCAR3 HCAR2	8.20e-07	2	32	2	30154797
Pubmed	Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a.	HCAR3 HCAR2	8.20e-07	2	32	2	38007572
Pubmed	(D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G.	HCAR3 HCAR2	8.20e-07	2	32	2	15929991
Pubmed	The role of the C-terminus of the human hydroxycarboxylic acid receptors 2 and 3 in G protein activation using Gα-engineered yeast cells.	HCAR3 HCAR2	8.20e-07	2	32	2	26656756
Pubmed	Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium.	HCAR3 HCAR2	8.20e-07	2	32	2	19223991
Pubmed	The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival.	HCAR3 HCAR2	8.20e-07	2	32	2	24371223
Pubmed	Lactate-induced activation of HCA2 improves survival in mice with sepsis.	HCAR3 HCAR2	8.20e-07	2	32	2	30951370
Pubmed	GPR109A Expression in the Murine Min6 Pancreatic Beta Cell Line, and Its Relation with Glucose Metabolism and Inflammation.	HCAR3 HCAR2	8.20e-07	2	32	2	26116596
Pubmed	Expression and activation of the ketone body receptor HCAR2/GPR109A promotes preservation of retinal endothelial cell barrier function.	HCAR3 HCAR2	8.20e-07	2	32	2	35649469
Pubmed	Niacin fine-tunes energy homeostasis through canonical GPR109A signaling.	HCAR3 HCAR2	8.20e-07	2	32	2	30596513
Pubmed	Molecular identification of nicotinic acid receptor.	HCAR3 HCAR2	8.20e-07	2	32	2	12646212
Pubmed	The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer's disease.	HCAR3 HCAR2	8.20e-07	2	32	2	35320002
Pubmed	GPR109A expressed on medullary thymic epithelial cells affects thymic Treg development.	HCAR3 HCAR2	8.20e-07	2	32	2	37595951
Pubmed	Biased allosteric activation of ketone body receptor HCAR2 suppresses inflammation.	HCAR3 HCAR2	8.20e-07	2	32	2	37597514
Pubmed	PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect.	HCAR3 HCAR2	8.20e-07	2	32	2	12563315
Pubmed	The hypophagic response to heat stress is not mediated by GPR109A or peripheral β-OH butyrate.	HCAR3 HCAR2	8.20e-07	2	32	2	26936786
Pubmed	High dietary niacin may increase prostaglandin formation but does not increase tumor formation in ApcMin/+ mice.	HCAR3 HCAR2	8.20e-07	2	32	2	21774590
Pubmed	Hydroxycarboxylic Acid Receptor 2, a Pleiotropically Linked Receptor for the Multiple Sclerosis Drug, Monomethyl Fumarate. Possible Implications for the Inflammatory Response.	HCAR3 HCAR2	8.20e-07	2	32	2	34084164
Pubmed	GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.	HCAR3 HCAR2	8.20e-07	2	32	2	16322797
Pubmed	The Role of GPR109a Signaling in Niacin Induced Effects on Fed and Fasted Hepatic Metabolism.	HCAR3 HCAR2	8.20e-07	2	32	2	33924461
Pubmed	Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE.	HCAR3 HCAR2	8.20e-07	2	32	2	24691444
Pubmed	Activation of HCA2 regulates microglial responses to alleviate neurodegeneration in LPS-induced in vivo and in vitro models.	HCAR3 HCAR2	8.20e-07	2	32	2	36991440
Pubmed	BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.	HCAR3 HCAR2	8.20e-07	2	32	2	31914599
Pubmed	Deorphanization of GPR109B as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis.	HCAR3 HCAR2	8.20e-07	2	32	2	19561068
Pubmed	Ketone Body 3-Hydroxybutyrate Ameliorates Atherosclerosis via Receptor Gpr109a-Mediated Calcium Influx.	HCAR3 HCAR2	8.20e-07	2	32	2	33977048
Pubmed	Butyrate ameliorates caerulein-induced acute pancreatitis and associated intestinal injury by tissue-specific mechanisms.	HCAR3 HCAR2	8.20e-07	2	32	2	31347703
Pubmed	Niacin increases adiponectin and decreases adipose tissue inflammation in high fat diet-fed mice.	HCAR3 HCAR2	8.20e-07	2	32	2	23967184
Pubmed	Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages.	HCAR3 HCAR2	8.20e-07	2	32	2	25320346
Pubmed	Nicotinic acid receptor agonists.	HCAR3 HCAR2	8.20e-07	2	32	2	18983141
Pubmed	Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells.	HCAR3 HCAR2	2.46e-06	3	32	2	17008386
Pubmed	Effects of high fat diet on GPR109A and GPR81 gene expression.	HCAR3 HCAR2	2.46e-06	3	32	2	22842580
Pubmed	The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages.	HCAR3 HCAR2	2.46e-06	3	32	2	24845831
Pubmed	Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression.	HCAR3 HCAR2	2.46e-06	3	32	2	22914621
Pubmed	Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases.	HCAR3 HCAR2	2.46e-06	3	32	2	34852802
Pubmed	Niacin protects against abdominal aortic aneurysm formation via GPR109A independent mechanisms: role of NAD+/nicotinamide.	HCAR3 HCAR2	2.46e-06	3	32	2	31710686
Pubmed	Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A.	HCAR3 HCAR2	2.46e-06	3	32	2	32358041
Pubmed	Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice.	HCAR3 HCAR2	2.46e-06	3	32	2	20664170
Pubmed	Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.	HCAR3 HCAR2	2.46e-06	3	32	2	24226773
Pubmed	Activation of microglial GPR109A alleviates thermal hyperalgesia in female lupus mice by suppressing IL-18 and glutamatergic synaptic activity.	HCAR3 HCAR2	2.46e-06	3	32	2	34919284
Pubmed	Induction of the cystine/glutamate exchanger SLC7A11 in retinal pigment epithelial cells by the antipsoriatic drug monomethylfumarate.	HCAR3 HCAR2	2.46e-06	3	32	2	23404113
Pubmed	Niacin receptor GPR109A inhibits insulin secretion and is down-regulated in type 2 diabetic islet beta-cells.	HCAR3 HCAR2	2.46e-06	3	32	2	27570060
Pubmed	Hyperhomocysteinemia is detrimental to pregnancy in mice and is associated with preterm birth.	HCAR3 HCAR2	2.46e-06	3	32	2	23579073
Pubmed	Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells.	HCAR3 HCAR2	2.46e-06	3	32	2	21317532
Pubmed	Short-chain fatty acids directly exert anti-inflammatory responses in podocytes and tubular epithelial cells exposed to high glucose.	HCAR3 HCAR2	2.46e-06	3	32	2	37215085
Pubmed	Niacin stimulates adiponectin secretion through the GPR109A receptor.	HCAR3 HCAR2	2.46e-06	3	32	2	19141678
Pubmed	Oral Dimethyl Fumarate Targets HCA2-Expressing Skin Cells in the Imiquimod Mouse Model.	HCAR3 HCAR2	2.46e-06	3	32	2	35189149
Pubmed	Deficiency of Prebiotic Fiber and Insufficient Signaling Through Gut Metabolite-Sensing Receptors Leads to Cardiovascular Disease.	HCAR3 HCAR2	2.46e-06	3	32	2	32093510
Pubmed	Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8.	HCAR3 HCAR2	2.46e-06	3	32	2	20033346
Pubmed	The Butyrate-Producing Bacterium Clostridium butyricum Suppresses Clostridioides difficile Infection via Neutrophil- and Antimicrobial Cytokine-Dependent but GPR43/109a-Independent Mechanisms.	HCAR3 HCAR2	2.46e-06	3	32	2	33597149
Pubmed	International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B).	HCAR3 HCAR2	2.46e-06	3	32	2	21454438
Pubmed	Clostridium butyricum upregulates GPR109A/AMPK/PGC-1α and ameliorates acute pancreatitis-associated intestinal barrier injury in mice.	HCAR3 HCAR2	4.92e-06	4	32	2	38761195
Pubmed	Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis.	HCAR3 HCAR2	4.92e-06	4	32	2	24412617
Pubmed	Niacin activates the PI3K/Akt cascade via PKC- and EGFR-transactivation-dependent pathways through hydroxyl-carboxylic acid receptor 2.	HCAR3 HCAR2	4.92e-06	4	32	2	25375133
Pubmed	Peroxisome proliferator-activated receptor gamma regulates expression of the anti-lipolytic G-protein-coupled receptor 81 (GPR81/Gpr81).	HCAR3 HCAR2	4.92e-06	4	32	2	19633298
Pubmed	Gpr109a Limits Microbiota-Induced IL-23 Production To Constrain ILC3-Mediated Colonic Inflammation.	HCAR3 HCAR2	4.92e-06	4	32	2	29514953
Pubmed	The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.	HCAR3 HCAR2	4.92e-06	4	32	2	25686106
Pubmed	Dietary Fiber and Bacterial SCFA Enhance Oral Tolerance and Protect against Food Allergy through Diverse Cellular Pathways.	HCAR3 HCAR2	4.92e-06	4	32	2	27332875
Pubmed	β-Hydroxybutyrate suppresses colorectal cancer.	HCAR3 HCAR2	8.19e-06	5	32	2	35477756
Pubmed	Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome.	HCAR3 HCAR2	8.19e-06	5	32	2	25828455
Pubmed	Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81.	HCAR3 HCAR2	8.19e-06	5	32	2	19047060
Pubmed	GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy.	HCAR3 HCAR2	8.19e-06	5	32	2	22427566
Pubmed	Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder.	HCAR3 HCAR2	1.23e-05	6	32	2	19502010
Pubmed	Chlamydia pneumoniae Hijacks a Host Autoregulatory IL-1β Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis.	HCAR3 HCAR2	1.23e-05	6	32	2	29937375
Pubmed	Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity.	HCAR3 HCAR2	1.72e-05	7	32	2	32901017
Pubmed	Vagal neuron expression of the microbiota-derived metabolite receptor, free fatty acid receptor (FFAR3), is necessary for normal feeding behavior.	HCAR3 HCAR2	2.29e-05	8	32	2	34626852
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ACIN1 SALL3 CNOT2 GLYR1 PLXNA2 ZBTB21	8.35e-05	808	32	6	20412781
Pubmed	Microbiota modulate sympathetic neurons via a gut-brain circuit.	HCAR3 HCAR2	8.55e-05	15	32	2	32641826
Pubmed	Genomic analysis of mouse retinal development.	ACIN1 SERINC5 SALL3 FZD3 GLYR1 LRRC41	2.75e-04	1006	32	6	15226823
Pubmed	Molecular mapping of developing dorsal horn-enriched genes by microarray and dorsal/ventral subtractive screening.	SALL3 PLXNA2	4.00e-04	32	32	2	16516881
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ACIN1 TICRR SALL3 CNOT2 FARP1 GLYR1	4.09e-04	1084	32	6	11544199
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ACIN1 PLXNA2 PPM1E RALGAPB	5.13e-04	407	32	4	12693553
Cytoband	5q14.1	SERINC5 ACOT12	3.43e-04	39	32	2	5q14.1
Cytoband	Ensembl 112 genes in cytogenetic band chr20q11	TSPY26P AAR2 RALGAPB	6.88e-04	248	32	3	chr20q11
Cytoband	12q24.31	HCAR3 HCAR2	1.44e-03	80	32	2	12q24.31
Cytoband	19p12	ZNF431 ZNF738	1.81e-03	90	32	2	19p12
Cytoband	Ensembl 112 genes in cytogenetic band chr19p12	ZNF431 ZNF738	3.30e-03	122	32	2	chr19p12
Cytoband	Ensembl 112 genes in cytogenetic band chr5q14	SERINC5 ACOT12	4.08e-03	136	32	2	chr5q14
GeneFamily	Hydroxy-carboxylic acid receptors	HCAR3 HCAR2	3.85e-06	3	21	2	200
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	EPB41L4A FARP1	1.52e-03	50	21	2	1293
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF431 SALL3 ZNF229 ZBTB21	8.61e-03	718	21	4	28
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH12 SPAG17 RGS22 PPM1E	6.86e-06	178	31	4	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH12 SPAG17 RGS22 PPM1E	7.81e-06	184	31	4	5daff849625f2f41d56615569c0ed59cd733b34c
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	DNAH12 SPAG17 RGS22 PPM1E	7.98e-06	185	31	4	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH12 SPAG17 RGS22 PPM1E	8.51e-06	188	31	4	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	DNAH12 SPAG17 RGS22	1.14e-04	136	31	3	67d736096d6b6ddb4722809557f5e987063b8d23
ToppCell	Substantia_nigra-Macroglia-CSF_related\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	DNAH12 SPAG17 RGS22	1.14e-04	136	31	3	47663c5d81c766a333207a44fc5b58b07309ee76
ToppCell	Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)--\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	DNAH12 SPAG17 RGS22	1.14e-04	136	31	3	6d2e5b871f4cf8d64e6fe0be666fb3490797c635
ToppCell	Substantia_nigra-Macroglia-CSF_related-EPENDYMAL\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	DNAH12 SPAG17 RGS22	1.14e-04	136	31	3	3f6cec8d52c84191f7f6e2dd4dc47524dfd5b21b
ToppCell	Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	DNAH12 SPAG17 RGS22	1.14e-04	136	31	3	fd4269d194c7c11c6ab4383393a01efab05cbace
ToppCell	Ciliated_cells-B-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	1.49e-04	149	31	3	6399c5a2f06d79f020dece252526f1c0c110d569
ToppCell	Ciliated_cells-A-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 PPM1E	1.95e-04	163	31	3	43194c6127df1ce3d29242f719645de3c11fd7c0
ToppCell	Ciliated_cells-B-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	1.98e-04	164	31	3	fd30c55d0d75ef8b9396435d836187168095152b
ToppCell	Ciliated_cells-B-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	1.98e-04	164	31	3	0e9961acbb1d6c0089e6805ba6756736fa4d8bed
ToppCell	lung-Ciliated_Epithelia\|lung / shred on tissue and cell subclass	DNAH12 SPAG17 RGS22	2.09e-04	167	31	3	26cf1cfa58ee74794449a87eb19cd896e1ec8892
ToppCell	E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH12 SPAG17 RGS22	2.13e-04	168	31	3	fa7c0303918cea04e3f4c4f3cb079be19004d214
ToppCell	E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH12 SPAG17 RGS22	2.13e-04	168	31	3	7edcab103c69e928d5c19a0d218ffb3ae32f9e70
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAH12 SPAG17 RGS22	2.13e-04	168	31	3	9a8709d34865cfa668d8f3335dc34fc86fc32482
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH12 SPAG17 RGS22	2.17e-04	169	31	3	8bca402e144819cb9a8d431d6bf9429be2fff6d6
ToppCell	3'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF431 HCAR2 EPB41L4A	2.24e-04	171	31	3	317b70d72a4ca5336cfb6a49dc57f8e2a8a1c736
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Deuterosomal\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	DNAH12 SPAG17 CYP7A1	2.24e-04	171	31	3	52aec5f6677fe2f7a36fb5b18117a4cffaeff58f
ToppCell	Mesenchymal_cells-Osteo-CAR\|Mesenchymal_cells / Lineage and Cell class	DNAH12 PLXNA2 PPM1E	2.36e-04	174	31	3	430e3cd61bc2a471959faa40e817aa4dd7d82d28
ToppCell	Ciliated_cells-A-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	2.44e-04	176	31	3	1c364155f46b9a7c995bdc2cc2333c437cd90f5b
ToppCell	Ciliated_cells-B-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	2.48e-04	177	31	3	c38138fb5ad9766c2d240811210c854338cd612e
ToppCell	Ciliated_cells-A-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	2.52e-04	178	31	3	255473ee6df8a13079fb3bb61038162a40cb4c2c
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HCAR3 HCAR2 PLXNA2	2.56e-04	179	31	3	d16dc58b5b22762a5a3c875563ced18022d08908
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH12 SPAG17 RGS22	2.56e-04	179	31	3	5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH12 SPAG17 RGS22	2.61e-04	180	31	3	92fb01b91261b3103454924cde56add337b41844
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH12 SPAG17 RGS22	2.65e-04	181	31	3	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	Adult-Epithelial-ciliated_cell-D122\|Adult / Lineage, Cell type, age group and donor	DNAH12 SPAG17 RGS22	2.69e-04	182	31	3	7ded554a4b441e6496db673ba206c0d76ccad7d9
ToppCell	21-Trachea-Epithelial-Multiciliated_precursor\|Trachea / Age, Tissue, Lineage and Cell class	DNAH12 SPAG17 ZBTB21	2.69e-04	182	31	3	6e35892fa959ee31591850ded8f1088195ddeb01
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	DNAH12 SPAG17 RGS22	2.69e-04	182	31	3	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	DNAH12 SPAG17 PPM1E	2.69e-04	182	31	3	000eca5baa6eb2335a1e6d76a13fff5382b0e150
ToppCell	Ciliated_cells-B-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	2.69e-04	182	31	3	e44c4810dc7d51a76b86d7623f8e4c4d8b4bf2fc
ToppCell	Ciliated_cells-B-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	2.69e-04	182	31	3	e93968f800bfeb258e4e834fc8bf92d1cb72cd73
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPAG17 CYP7A1 RGS22	2.78e-04	184	31	3	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPAG17 CYP7A1 RGS22	2.78e-04	184	31	3	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPAG17 CYP7A1 RGS22	2.78e-04	184	31	3	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH12 SPAG17 RGS22	2.78e-04	184	31	3	797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b
ToppCell	E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH12 SPAG17 RGS22	2.78e-04	184	31	3	77d5b60a20b277f589b18f7a131142a7ef2dac17
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	DNAH12 SPAG17 RGS22	2.82e-04	185	31	3	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH12 SPAG17 RGS22	2.82e-04	185	31	3	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	15-Trachea-Epithelial-Multiciliated_precursor\|Trachea / Age, Tissue, Lineage and Cell class	DNAH12 SPAG17 ZBTB21	2.82e-04	185	31	3	9a8b8360d99375b726ca8e3c9a3f9b08919892d7
ToppCell	Ciliated_cells-B-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	2.82e-04	185	31	3	4fc7113d3dadc716ec5a8e62b58543cc00ce5b16
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	2.82e-04	185	31	3	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	Ciliated_cells-A-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	2.82e-04	185	31	3	d77ca57b02125a3a57a37f4aed20c89803b7d551
ToppCell	P28-Epithelial-airway_epithelial_cell-club_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DNAH12 SPAG17 RGS22	2.87e-04	186	31	3	a26811481668fa25c48a064a56c198685693ad8d
ToppCell	390C-Epithelial_cells-Epithelial-F_(Ciliated)\|390C / Donor, Lineage, Cell class and subclass (all cells)	DNAH12 SPAG17 RGS22	2.87e-04	186	31	3	708c5edefe36c91df27cf53c1b5101fb2030cc5a
ToppCell	P28-Epithelial-airway_epithelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DNAH12 SPAG17 RGS22	2.87e-04	186	31	3	df80f101954b8ec6ccdb03e702de22e70b65181f
ToppCell	390C-Epithelial_cells-Epithelial-F_(Ciliated)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	DNAH12 SPAG17 RGS22	2.87e-04	186	31	3	029390c4aaf64e6bcd86124cd4a6dd2e6f3a374b
ToppCell	Ciliated_cells-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	2.87e-04	186	31	3	f72267d533fd0c5280d9741ceee3dd116300a7e4
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH12 SPAG17 RGS22	2.87e-04	186	31	3	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	21-Trachea-Epithelial-Intermediate_ciliated\|Trachea / Age, Tissue, Lineage and Cell class	DNAH12 SPAG17 RGS22	2.92e-04	187	31	3	1a2178a195d078d1963947b327c6d0d4f2f48341
ToppCell	COPD-Epithelial-Ciliated\|COPD / Disease state, Lineage and Cell class	DNAH12 SPAG17 RGS22	2.92e-04	187	31	3	f0fd0792f6926f705d175f6e6fd480f12c7a3bd4
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH12 SPAG17 RGS22	2.92e-04	187	31	3	e61992de4f98eeea08b43213850769d923f8db48
ToppCell	Ciliated_cells-B-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	2.92e-04	187	31	3	bc1f33f332ac939c2425f510173430ca2ba0c3ee
ToppCell	390C-Epithelial_cells-Epithelial-F_(Ciliated)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DNAH12 SPAG17 RGS22	2.92e-04	187	31	3	88f785932e67c613db0dda84496de351359ed962
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH12 SPAG17 RGS22	2.92e-04	187	31	3	9e10ed56090d82589bc457788282f664b70ace4b
ToppCell	390C-Epithelial_cells-Epithelial-F_(Ciliated)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DNAH12 SPAG17 RGS22	2.92e-04	187	31	3	8896a00b30d11b90ca42726d4e122174a30b161b
ToppCell	Ciliated_cells-B-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	2.92e-04	187	31	3	6fa38dbccca36bc7a4fef46de74c6688f599f421
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	FARP1 AAR2 RALGAPB	2.96e-04	188	31	3	14bc73cf79c79c9f208369fd8d498e5b26e0114d
ToppCell	367C-Epithelial_cells-Epithelial-F_(Ciliated)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DNAH12 SPAG17 RGS22	2.96e-04	188	31	3	da59b5c0a4b11690a39a964c1a0a83e66aa0972b
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	DNAH12 SPAG17 RGS22	2.96e-04	188	31	3	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	(7)_Epithelial_cells-(7)_Epithelial-F_(Ciliated)\|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	DNAH12 SPAG17 RGS22	2.96e-04	188	31	3	5ba5cbb403518026e9040379fb5d99339ea977d8
ToppCell	21-Trachea-Epithelial-Multiciliated_cell\|Trachea / Age, Tissue, Lineage and Cell class	DNAH12 SPAG17 RGS22	2.96e-04	188	31	3	803bf76a85b3033d2a04b08dd2c03ce9c15529ba
ToppCell	367C-Epithelial_cells-Epithelial-F_(Ciliated)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DNAH12 SPAG17 RGS22	2.96e-04	188	31	3	82c006f43c93f4a867953a446864f02b44536a23
ToppCell	Ciliated_cells-B-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	2.96e-04	188	31	3	606907c865bd2f11bb6474932716550f7723d858
ToppCell	Epithelial-ciliated_cell\|World / Lineage, Cell type, age group and donor	DNAH12 SPAG17 RGS22	2.96e-04	188	31	3	61a459f3fe57e5728efc72637ff2edc2d343492b
ToppCell	(7)_Epithelial-F_(Ciliated)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	DNAH12 SPAG17 RGS22	2.96e-04	188	31	3	9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3
ToppCell	Epithelial-Epithelial-D_(Ciliated)\|Epithelial / shred on cell class and cell subclass (v4)	DNAH12 SPAG17 RGS22	2.96e-04	188	31	3	8f30535a32968a81a304315a49c0d90a77d36948
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH12 SPAG17 RGS22	3.01e-04	189	31	3	cd4746ea6ae48a7dd14a2960d38d9445a738cf2c
ToppCell	Control-Epithelial-Ciliated\|Control / Disease state, Lineage and Cell class	DNAH12 SPAG17 RGS22	3.01e-04	189	31	3	c007fccd08728db3ea99af9da91d67b9b16dabb3
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH12 SPAG17 RGS22	3.01e-04	189	31	3	02c6128a9ab5818e0881dcadafdad5f08b9a67cf
ToppCell	COVID-19-lung-Ciliated\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DNAH12 SPAG17 RGS22	3.01e-04	189	31	3	a2da5debd10f27b1280b40141ef0bfef007cc72c
ToppCell	Adult-Epithelial-ciliated_cell\|Adult / Lineage, Cell type, age group and donor	DNAH12 SPAG17 RGS22	3.01e-04	189	31	3	b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCell	343B-Epithelial_cells-Epithelial-F_(Ciliated)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DNAH12 SPAG17 RGS22	3.01e-04	189	31	3	57ab947b81dbd9d3e896be89e28c4a62cf720837
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	DNAH12 SPAG17 RGS22	3.01e-04	189	31	3	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH12 SPAG17 RGS22	3.01e-04	189	31	3	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	343B-Epithelial_cells-Epithelial-F_(Ciliated)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DNAH12 SPAG17 RGS22	3.01e-04	189	31	3	ebc16b8eab84167d74446783d7e802acedc6b9c6
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH12 SPAG17 RGS22	3.01e-04	189	31	3	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	DNAH12 SPAG17 RGS22	3.01e-04	189	31	3	dc440015949a768188c67661b6be63b1ead1a0f0
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH12 SPAG17 RGS22	3.01e-04	189	31	3	164ea92ff6a1aa2ead1c9b8f64f99a9d65437232
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH12 SPAG17 RGS22	3.01e-04	189	31	3	a3cd4c2da4feb9bdcd8957f3e344d095da1367b8
ToppCell	Epithelial-D_(Ciliated)\|World / shred on cell class and cell subclass (v4)	DNAH12 SPAG17 RGS22	3.01e-04	189	31	3	0bf560b595c7a8450a46bc821b742b67965bd9f9
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH12 SPAG17 RGS22	3.01e-04	189	31	3	93b1026bb1ba759e5704561c9a5de14a30c08894
ToppCell	Ciliated_cells-A\|World / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	3.05e-04	190	31	3	cd87731aaa7d252424f79cfce9f7931457f17bdf
ToppCell	Epithelial_cells-Ciliated_cells-B\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	3.05e-04	190	31	3	426a4806f6e39d4d57c6746609d30bb3ca62df7d
ToppCell	Ciliated_cells-B\|World / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	3.05e-04	190	31	3	7031fbedc13be1a00f6333ad6d51849c3739c2e6
ToppCell	343B-Epithelial_cells-Epithelial-F_(Ciliated)\|343B / Donor, Lineage, Cell class and subclass (all cells)	DNAH12 SPAG17 RGS22	3.05e-04	190	31	3	169e600e95878000acf5d11f813f9028c7249646
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	DNAH12 SPAG17 RGS22	3.05e-04	190	31	3	a90a38fccdbf75a286b4d258fc54920c02b282f7
ToppCell	343B-Epithelial_cells-Epithelial-F_(Ciliated)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	DNAH12 SPAG17 RGS22	3.05e-04	190	31	3	0cc36117c793d83cf4a1f66f47758a07d6712bd3
ToppCell	Epithelial_cells-Ciliated_cells-A\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	DNAH12 SPAG17 RGS22	3.05e-04	190	31	3	549d813a8f23b175875e53347928941f143e236c
ToppCell	cellseq2-Epithelial-Epithelial_Airway\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH12 SPAG17 RGS22	3.05e-04	190	31	3	17829f4de31b3d9e4d71ba4817d18842aa699773
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH12 SPAG17 RGS22	3.10e-04	191	31	3	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH12 SPAG17 RGS22	3.10e-04	191	31	3	7b5da29109aa28768c67653a1bc0f385c2d2269b
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DNAH12 SPAG17 RGS22	3.10e-04	191	31	3	2a8e6d560907e71e9f6e190ca0667da804e25641
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH12 SPAG17 RGS22	3.10e-04	191	31	3	2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d
ToppCell	E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH12 SPAG17 RGS22	3.10e-04	191	31	3	acd844b477a069b2dcf07b2998e1b5c87dc0eb94
ToppCell	Healthy_Control-Epithelial-Epithelial\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	DNAH12 SPAG17 RGS22	3.10e-04	191	31	3	15b9386b26caaa7d15f704c4a18881e1ce918a21
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH12 SPAG17 RGS22	3.10e-04	191	31	3	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	356C-Epithelial_cells-Epithelial-F_(Ciliated)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DNAH12 SPAG17 RGS22	3.10e-04	191	31	3	6d2cf41ee946137c039ddcc13593fc3f670afbba
Drug	Niacin	HCAR3 HCAR2	1.07e-05	4	31	2	DB00627
Drug	acifran	HCAR3 HCAR2	1.79e-05	5	31	2	ctd:C036804
Disease	Colorectal Carcinoma	ACIN1 SALL3 SPAG17 EDRF1 PPM1E	6.54e-04	702	30	5	C0009402
Disease	Skin Neoplasms	HCAR3 HCAR2	1.65e-03	59	30	2	C0037286
Disease	Malignant neoplasm of skin	HCAR3 HCAR2	1.65e-03	59	30	2	C0007114
Disease	HDL cholesterol change measurement, physical activity	HCAR3 HCAR2	1.82e-03	62	30	2	EFO_0003940, EFO_0007805
Disease	cortical surface area measurement	TICRR TSPY26P PSTPIP1 SPAG17 FZD3 PLXNA2	2.05e-03	1345	30	6	EFO_0010736
Disease	non-melanoma skin carcinoma	FARP1 RGS22 AAR2	2.43e-03	265	30	3	EFO_0009260
Disease	physical activity	FARP1 AAR2	3.62e-03	88	30	2	EFO_0003940
Disease	obsessive-compulsive disorder	HCAR3 HCAR2	4.65e-03	100	30	2	EFO_0004242
Disease	Oral ulcer	HCAR3 HCAR2	5.30e-03	107	30	2	HP_0000155

Protein segments in the cluster

Peptide	Gene	Start	Entry
EAFWIDKIKSHCFVT	ACIN1	1041	Q9UKV3
FQAHLTKKFRWDFAA	AAR2	351	Q9Y312
CWAHPFLKSVDMFKF	ACOT12	221	Q8WYK0
QFKDAFWCRDFTAHT	PSTPIP1	6	O43586
CRFLLWAFTIFHKAQ	HAPLN2	11	Q9GZV7
WKKSFSCFEKGIHNF	EDRF1	876	Q3B7T1
IFCFHLKSWKSSRIF	HCAR2	51	Q8TDS4
WFAFLLHKFLKECAG	PLXNA2	1441	O75051
VLWFHAREISFKACF	OR51T1	86	Q8NGJ9
CFFVKFFGTEDHAWI	GLYR1	41	Q49A26
AWEKLLFGVCFFHAL	DNAH12	2641	Q6ZR08
FSKLHEICCSWVKDF	PPM1E	206	Q8WY54
FCKSFWKICVEHHAF	FARP1	301	Q9Y4F1
KKTCFEWASFFHGRR	FZD3	501	Q9NPG1
DLAVSKHFFSLSWFC	GCRG224	11	Q8WZA8
DWKKFHFATSAKAFG	CYP7A1	96	P22680
FFFEARSKTACKHLW	EPB41L4A	271	Q9HCS5
FKWADFLEHQRSCTK	SALL3	61	Q9BXA9
VTCWRAKFMEAFFSH	LRRC41	121	Q15345
FFFTKFCEHSGNKLW	RGS22	676	Q8NE09
IFCFHLKSWKSSRIF	HCAR3	51	P49019
KDFFEKTWRHTASSK	SPAG17	1866	Q6Q759
FFDCLNWRKVAKEFH	CNOT2	501	Q9NZN8
ECGKAFKWFSTLTRH	ZNF431	236	Q8TF32
ECGKAFKWFSTLTRH	ZNF738	236	Q8NE65
KLCHRTFKTAFSLWS	ZBTB21	1046	Q9ULJ3
CRFGLARVHWAFKFF	TICRR	36	Q7Z2Z1
KSCRAHIHNGFWFFK	SERINC5	116	Q86VE9
LFGSWLFDAAFVHCK	RALGAPB	446	Q86X10
RFFSHKELSSCKIWE	ZNF229	96	Q9UJW7
HSRTGCKFKFRFWSN	TSPY26P	231	Q9H489
FFICFFGHRFWKTEL	TM7SF3	306	Q9NS93